Flurazepam Hydrochloride Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Flurazepam Hydrochloride Capsule (capsule) from Rising Pharma Holdings, Inc. with status Current. The shortage was first posted on 08/03/2022. Reported reason: Regulatory delay
Shortage Details
- Status
- Current
- Company
- Rising Pharma Holdings, Inc.
- Package NDC
- 0378-4430-01
- Dosage Form
- Capsule
- Presentation
- Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)
- Initial Posting
- 08/03/2022
- Revised Date
Reason
Regulatory delay